ArticleCancer research2024

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Manuel Torres-Diz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.